Skip to main content

Table 1 Effect of TXA

From: The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial

Events RR 95% CI
Myocardial infarction 0.96 0.48-1.90
Stroke 1.25 0.47-3.31
Deep venous thrombosis 0.77 0.37-1.61
Renal failure 0.73 0.16-3.32